We have recently hypothesized (41) that a SARS-CoV-2-induced decrease in ACE2 expression and/or inhibition of ACE2 peptidase function could result in a feedback control leading to increased production of Ang II expected to aggravate the severity of COVID-19. The gene discussed is AGT; the disease is COVID-19.